Cris De Luca
InvestorPartner at Sanofi Ventures · Board director at Click Therapeutics
Cambridge, Massachusetts
Writes $2M – $20M checks · typically $10M
Find your path to Cris
604 people in our graph share verified history with Cris — schools, employers, funds. One of them is your warm intro.
Alain le LouxunlockedCris: together at Getronics (2005–2006)
×3Cris: together at Johnson & Johnson
×7Cris: together at Deutsche Bank
Cris: together at Zurich Scudder Investments
About
Cris De Luca, former Global Head of Digital Innovation at Johnson & Johnson, focuses on AI platforms that identify, study, and reach patients for drug development while emphasizing responsible AI.
Invests in
AI & Machine LearningBiotechData & InfrastructureHealthtechMedical Devices
Board director at Click Therapeutics
Intro paths
→
In turn, Cris can intro founders to Click Therapeutics's investors below.
Click Therapeutics's investors · 10
7wire VenturesChicago · $100K – $5M checks · since 2025Accelmed PartnersMiami · since 2021Boehringer Ingelheim Venture FundIngelheim am Rhein · $16.2M checksH.I.G. CapitalMiamiH.I.G. HealthBridge PartnersMiami · $5M – $40M checksHealth Catalyst CapitalNew YorkHikma VenturesLondon · $5M checksNational Institutes of Health (NIH)since 2018Sanofi VenturesCambridge · $5M checks · since 2021Supernode VenturesNew York · $500K – $1.3M checks
Co-founders at Click Therapeutics
DB
David B. KleinFounder and CEO
DK
David KleinExecutive Officer, Director
Experience
- FIFA World Cup™ Boston 2026Host City Ambassador, Boston 2026current2026 — presentBoston, MA
- SanofiPartner, AI and Digital Investments at Sanofi Venturescurrent2020 — presentCambridge, Massachusetts, United States
- BranchLabBoard Observercurrent2026 — present
- Trial LibraryBoard Observercurrent2025 — present
- QuantHealthBoard Observercurrent2025 — present
- EmpaticaBoard Membercurrent2022 — presentCambridge, Massachusetts, United States
- NucleaiBoard Membercurrent2022 — presentTel Aviv, Israel
- Medisafe®Board Membercurrent2021 — presentBoston, Massachusetts, United States
- Click Therapeutics, Inc.Board Membercurrent2020 — presentNew York, United States
- Omada HealthBoard Observer2021 — 2025San Francisco Bay Area
- AetionBoard Observer2020 — 2025New York, United States
- Carbon HealthBoard Member2023 — 2025San Francisco, California, United States
- Common SensingBoard Observer2020 — 2021Cambridge, Massachusetts, United States
- Science 37Investor2020 — 2021
- Johnson & JohnsonHead, JLABS @ Boston2019 — 2020Greater Boston Area
- Johnson & JohnsonGlobal Head, Digital Innovation, Johnson & Johnson Innovation2013 — 2020Cambridge, Ma
- FundRxVenture Partner2018 — 2020
- Future EnergyCo-Founder2012 — 2015Cambridge, MA
- BrightMapPrincipal2011 — 2014Cambridge, MA
- Ultra Light StartupsCo-Founder2009 — 2013Boston, MA
- NovartisDirector, Emerging Technologies2011 — 2013Cambridge, ma
- NovartisGlobal Head of Operations, Research Computing Platforms2009 — 2011
- NovartisSr. Technology Manager, Digital Transformation2007 — 2009
- Boston UniversityGraduate Faculty Instructor, Computer Science Dept.2008 — 2011
- Deutsche BankTechnology Program Manager2005 — 2007
- GetronicsDevelopment Technology Manager2004 — 2006
- Deutsche BankMobile Computing Engineer2002 — 2005
- Zurich Scudder InvestmentsData Operations1999 — 2001
Skills & more
Artificial Intelligence (AI)4Business Innovation4Data Science9Wearable Computing58Healthcare Information Technology56Innovation Management46Start-ups99Entrepreneurship99Social Media26Project Management75Analytics62Business Development65
+12 more
Social NetworkingNetworkingMarketingVenture CapitalBusiness StrategyStrategic PartnershipsProject PlanningCommunity BuildingStrategic PlanningTeam LeadershipProblem SolvingInspirationLanguages English · French · Italian · Spanish
- Project Management Professional — Boston University
From Cris's professional profile.
Deals · 1
Click TherapeuticsBoard seat
via Sanofi Ventures · filed Nov 2021 · $52.1M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Sanofi Ventures
Anne
Investor at Sanofi Ventures
Becca
Investor at Sanofi Ventures
Chris
Investor at Sanofi Ventures
Christopher Gagliardi
Principal at Sanofi Ventures
Francesc Dosrius Lleonart
Associate Director of Investments at Sanofi Ventures
Jason P. Hafler
Managing Director at Sanofi Ventures
Kriti
Investor at Sanofi Ventures
Laia Crespo
Partner at Sanofi Ventures
Network5
Carrie Williams
Partner, Venture at McKesson Ventures
Christopher Gagliardi
Principal at Sanofi Ventures
Jason P. Hafler
Managing Director at Sanofi Ventures
Jim Trenkle
Investor at Sanofi Ventures
Laia Crespo
Partner at Sanofi Ventures
Investors connected to Cris in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Cris De Luca?
- Cris De Luca, former Global Head of Digital Innovation at Johnson & Johnson, focuses on AI platforms that identify, study, and reach patients for drug development while emphasizing responsible AI.
- Where does Cris De Luca work?
- Cris De Luca is Partner at Sanofi Ventures and Board director at Click Therapeutics.
- What does Cris De Luca invest in?
- Cris De Luca invests in AI & Machine Learning, Biotech, Data & Infrastructure, Healthtech, Medical Devices.
- What check size does Cris De Luca write?
- Cris De Luca typically writes checks of $2M – $20M.
- What boards does Cris De Luca sit on?
- Cris De Luca holds tracked board seats at Click Therapeutics.
- Where did Cris De Luca go to school?
- Cris De Luca studied at Boston University (Master of Science, Computer Information Science); MIT Professional Education (MIT Enterprise Invest, Venture Capital Program); Suffolk University - Sawyer Business School (Bachelor of Science, Business Administration).
Same school
Also attended Boston University417
Aydin SenkutFounder & Managing Partner at FelicisVinnie LauriaFounding Partner at Golden Gate VenturesJeff GrammerPartner at Rho VenturesGil GorenPartner at 83NorthJames LindenbaumCo-founder at HeavybitDave BiscegliaVenture Partner at Founder Collective
+ 411 more
Also attended MIT Professional Education42
Michael ZehnderHead of Digital Technology & Intelligence at Emerald Technology Ventures AgKanira ShahVenture Partner, Future Content Fund at IPR.VCElena Harumi StarkVP of Platform and Impact at AENUThomas DunleavyHead of Venture at Varys CapitalHugues BertinPartner at HCS CapitalLinda GreubManaging Partner at Avestria Ventures
+ 36 more
Also attended Suffolk University - Sawyer Business School12
John HarthorneFounder & Managing Director at Two Lanterns Venture PartnersRaf UrdanetaInvestor at Silversmith Capital PartnersTetsuya NagamochiDirector at SBI Ven CapitalEric NobleChief Financial Officer & Chief Compliance Officer at Peterson VenturesDhiren ChatlaniInvestor at ActyusAbdullah Abdulaziz AlOthaimChief Executive Officer at Mad'a Investment Company
+ 6 more
Shared employers
Also worked at Omada Health20
Shahram Seyedin-NoorFounder + Managing Partner at Civilization Ventures Management, LlcTomer BerkovitzManaging Partner at aMoonNick MarkInvestor at EPIC VENTURESDr. Sachin JainPresident and CEO at Team8Olivia MattaInvestor at SUPPLY CHANGE CAPITALSachin JainObvious Champion at Obvious Ventures
+ 14 more
Also worked at Johnson & Johnson229
Teresa ChanChief Financial Officer at Felicis VenturesKarthik ArdhanareeswaranInvestor at GV (Google Ventures)KobeFinance Director at Hummingbird VenturesMickelFinance & Risk Management at Hummingbird VenturesHal PazInvestor at Khosla VenturesNiall O'DonnellManaging Director at RiverVest Venture Partners
+ 223 more
Also worked at FundRx7
Dr Ruchi DanaPartner at MFV PartnersGurdane BhutaniManaging Partner at MBX CapitalZeshan MuhammediManaging Partner at MBX CapitalMarissa MooreInvestor at OMERS VenturesShrawan PatelCo-Founder & Head Mentor at PharmStars VenturesSahil ChopraPrincipal at Vertex Ventures HC
+ 1 more
Also worked at Novartis201
Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures
+ 195 more